{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:42:26Z","timestamp":1788295346818,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["11574165"],"award-info":[{"award-number":["11574165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["11874231"],"award-info":[{"award-number":["11874231"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31801134"],"award-info":[{"award-number":["31801134"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["18JCQNJC02000"],"award-info":[{"award-number":["18JCQNJC02000"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","award":["B07013"],"award-info":[{"award-number":["B07013"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.intimp.2019.105780","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T23:17:28Z","timestamp":1564528648000},"page":"105780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Rhein inhibits ATP-triggered inflammatory responses in rheumatoid rat fibroblast-like synoviocytes"],"prefix":"10.1016","volume":"75","author":[{"given":"Fen","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imshik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.105780_bb0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2019.105780_bb0010","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrrheum.2015.8","article-title":"Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges","volume":"11","author":"Smolen","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2019.105780_bb0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13075-016-1057-3","article-title":"Inhomogeneity of immune cell composition in the synovial sublining: linear mixed modelling indicates differences in distribution and spatial decline of CD68+ macrophages in osteoarthritis and rheumatoid arthritis","volume":"18","author":"Mucke","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2019.105780_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrrheum.2015.171","article-title":"Cytokines in rheumatoid arthritis - shaping the immunological landscape","volume":"12","author":"McInnes","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2019.105780_bb0025","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.molmed.2010.07.004","article-title":"Rheumatoid arthritis progression mediated by activated synovial fibroblasts","volume":"16","author":"Neumann","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.intimp.2019.105780_bb0030","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/ard.61.11.957","article-title":"MMPs and rheumatoid synovial fibroblasts: Siamese twins in joint destruction?","volume":"61","author":"M\u00fcller-Ladner","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2019.105780_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/578107","article-title":"Rhein: a review of pharmacological activities","volume":"2015","author":"Zhou","year":"2015","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.intimp.2019.105780_bb0040","first-page":"1624","article-title":"Research progress on the antitumor effects of rhein: literature review","volume":"17","author":"Wu","year":"2017","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.intimp.2019.105780_bb0045","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.phymed.2010.10.006","article-title":"Anti-angiogenic effect and mechanism of rhein from Rhizoma Rhei","volume":"18","author":"He","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2019.105780_bb0050","article-title":"Diacerein for osteoarthritis","volume":"2","author":"Fidelix","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.intimp.2019.105780_bb0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-2999(01)00990-6","article-title":"Diacerein suppresses the increase in plasma nitric oxide in rat adjuvant-induced arthritis","volume":"419","author":"Tamura","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105780_bb0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-2999(02)01898-8","article-title":"Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption","volume":"448","author":"Tamura","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105780_bb0065","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s10753-011-9407-4","article-title":"ER stress, p66shc, and p-Akt\/Akt mediate adjuvant-induced inflammation, which is blunted by argirein, a supermolecule and rhein in rats","volume":"35","author":"Cong","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2019.105780_bb0070","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.3892\/mmr.2015.3925","article-title":"Rhein inhibits lipopolysaccharide-induced intestinal injury during sepsis by blocking the toll-like receptor 4 nuclear factor-\u03baB pathway","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2019.105780_bb0075","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fphar.2016.00247","article-title":"A comprehensive and system review for the pharmacological mechanism of action of rhein, an active anthraquinone ingredient","volume":"7","author":"Sun","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105780_bb0080","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nature13085","article-title":"Nucleotide signalling during inflammation","volume":"509","author":"Idzko","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2019.105780_bb0085","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1056\/NEJMra1205750","article-title":"Purinergic signaling during inflammation","volume":"367","author":"Eltzschig","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2019.105780_bb0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11302-013-9357-4","article-title":"Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses","volume":"9","author":"Jacob","year":"2013","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.intimp.2019.105780_bb0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11302-015-9493-0","article-title":"P2X ion channel receptors and inflammation","volume":"12","author":"Burnstock","year":"2016","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.intimp.2019.105780_bb0100","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.4049\/jimmunol.180.11.7147","article-title":"P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage","volume":"180","author":"Pelegrin","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.105780_bb0105","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3892\/mmr.2013.1748","article-title":"P2X4 promotes interleukin-1\u03b2 production in osteoarthritis via NLRP1","volume":"9","author":"Fan","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2019.105780_bb0110","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/mol.112.083758","article-title":"P2X receptors as drug targets","volume":"83","author":"North","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105780_bb0115","first-page":"878","article-title":"Targeting the P2X7 receptor in rheumatoid arthritis: biological rationale for P2X7 antagonism","volume":"32","author":"McInnes","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2019.105780_bb0120","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar1883","article-title":"Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model","volume":"8","author":"Shou","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2019.105780_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2014.01.001","article-title":"Involvement of transient receptor potential melastatin-8 (TRPM8) in menthol-induced calcium entry, reactive oxygen species production and cell death in rheumatoid arthritis rat synovial fibroblasts","volume":"725","author":"Zhu","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105780_bb0130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/pr.110.003129","article-title":"Activation and regulation of purinergic P2X receptor channels","volume":"63","author":"Coddou","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.intimp.2019.105780_bb0135","first-page":"82","article-title":"Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors","volume":"58","author":"Jiang","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105780_bb0140","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1089\/ars.2007.1569","article-title":"Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategies","volume":"9","author":"Gelderman","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2019.105780_bb0145","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00109-008-0365-8","article-title":"Human rheumatoid synoviocytes express functional P2X7 receptors","volume":"86","author":"Caporali","year":"2008","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.intimp.2019.105780_bb0150","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2174\/187152712803581137","article-title":"P2X7 receptors: channels, pores and more","volume":"11","author":"Volont\u00e9","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.intimp.2019.105780_bb0155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1055\/s-2007-981469","article-title":"Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db\/db mice","volume":"115","author":"Jia","year":"2007","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.intimp.2019.105780_bb0160","first-page":"753","article-title":"In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes","volume":"25","author":"Martel-Pelletier","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2019.105780_bb0165","first-page":"S99","article-title":"In vitro effects of diacerein on NO production by chondrocytes in response to proinflammatory mediators","volume":"18","author":"De Isla","year":"2008","journal-title":"Biomed. Mater. Eng."},{"key":"10.1016\/j.intimp.2019.105780_bb0170","first-page":"433","article-title":"In vitro inhibition of IL-1beta catabolic effects on cartilage: a mechanism involved on diacerein anti-OA properties","volume":"45","author":"De Isla","year":"2008","journal-title":"Biorheology"},{"key":"10.1016\/j.intimp.2019.105780_bb0175","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.freeradbiomed.2014.04.001","article-title":"Rhein exerts pro- and anti-inflammatory actions by targeting IKK\u03b2 inhibition in LPS-activated macrophages","volume":"72","author":"Gao","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2019.105780_bb0180","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2147\/DDDT.S133069","article-title":"Rhein attenuates inflammation through inhibition of NF-\u03baB and NALP3 inflammasome in vivo and in vitro","volume":"11","author":"Ge","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2019.105780_bb0185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/joca.2000.0383","article-title":"Rhein, an active metabolite of diacerein, down-regulates the production of pro-matrix metalloproteinases-1, -3, -9 and -13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes","volume":"9","author":"Tamura","year":"2001","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.intimp.2019.105780_bb0190","first-page":"546","article-title":"Rhein, a diacerhein-derived metabolite, modulates the expression of matrix degrading enzymes and the cell proliferation of articular chondrocytes by inhibiting ERK and JNK-AP-1 dependent pathways","volume":"25","author":"Legendre","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2019.105780_bb0195","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.vph.2010.03.002","article-title":"Emodin and rhein inhibit LIGHT-induced monocytes migration by blocking of ROS production","volume":"53","author":"Heo","year":"2010","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105780_bb0200","article-title":"Rhein antagonizes P2X7 receptor in rat peritoneal macrophages","volume":"5","author":"Hu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2019.105780_bb0205","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/03009740802421996","article-title":"Rhein, the metabolite of diacerhein, reduces the proliferation of osteoarthritic chondrocytes and synoviocytes without inducing apoptosis","volume":"38","author":"Legendre","year":"2009","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.intimp.2019.105780_bb0210","first-page":"1443","article-title":"P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation","volume":"3","author":"Bours","year":"2011","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"10.1016\/j.intimp.2019.105780_bb0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2019.105780_bb0220","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/rheumatology\/ket178","article-title":"Emodin suppresses inflammatory responses and joint destruction in collagen-induced arthritic mice","volume":"52","author":"Hwang","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2019.105780_bb0225","article-title":"Anti-inflammatory and antiarthritic activity of anthraquinone derivatives in rodents","volume":"2014","author":"Kshirsagar","year":"2014","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.intimp.2019.105780_bb0230","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-019-04587-1","article-title":"Diacerein for the treatment of rheumatoid arthritis in patients with inadequate response to methotrexate: a pilot randomized, double-blind, placebo-controlled add-on trial","author":"Louthrenoo","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2019.105780_bb0235","article-title":"Anti-influenza A virus activity of rhein through regulating oxidative stress, TLR4, Akt, MAPK, and NF-\u03baB signal pathways","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2019.105780_bb0240","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.biocel.2013.02.009","article-title":"ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy","volume":"45","author":"Chen","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.intimp.2019.105780_bb0245","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1038\/emboj.2010.126","article-title":"P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain","volume":"29","author":"Ulmann","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.intimp.2019.105780_bb0250","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.4049\/jimmunol.1000436","article-title":"P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases","volume":"185","author":"Lopez-Castejon","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.105780_bb0255","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1126\/science.1132559","article-title":"ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors","volume":"314","author":"Chen","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.intimp.2019.105780_bb0260","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood-2010-10-313957","article-title":"Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation","volume":"117","author":"Riegel","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2019.105780_bb0265","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/408242","article-title":"Modulating P2X7 receptor signaling during rheumatoid arthritis: new therapeutic approaches for bisphosphonates","volume":"2012","author":"Baroja-Mazo","year":"2012","journal-title":"J. Osteoporos."},{"key":"10.1016\/j.intimp.2019.105780_bb0270","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1002\/jcp.27544","article-title":"P2X7, a critical regulator and potential target for bone and joint diseases","volume":"234","author":"Zeng","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2019.105780_bb0275","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s10753-013-9723-y","article-title":"Inhibition of P2X4 suppresses joint inflammation and damage in collagen-induced arthritis","volume":"37","author":"Li","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2019.105780_bb0280","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cbi.2014.10.031","article-title":"Anti-arthritic activity of luteolin in Freund's complete adjuvant-induced arthritis in rats by suppressing P2X4 pathway","volume":"226","author":"Shi","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.intimp.2019.105780_bb0285","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bcp.2004.11.012","article-title":"Multiple P2X and P2Y receptor subtypes in mouse J774, spleen and peritoneal macrophages","volume":"69","author":"Coutinho-Silva","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105780_bb0290","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/np50083a026","article-title":"Emodin, a protein tyrosine kinase inhibitor from Polygonumcuspidatum","volume":"55","author":"Jayasuriya","year":"1992","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.intimp.2019.105780_bb0295","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1021\/np9905259","article-title":"Anthraquinones and betaenone derivatives from the sponge-associated fungus Microsphaeropsis species: novel inhibitors of protein kinases","volume":"63","author":"Brauers","year":"2000","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.intimp.2019.105780_bb0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-1999-13953","article-title":"Emodin, an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor","volume":"65","author":"Yim","year":"1999","journal-title":"Planta Med."},{"key":"10.1016\/j.intimp.2019.105780_bb0305","doi-asserted-by":"crossref","first-page":"29618","DOI":"10.1074\/jbc.M004257200","article-title":"The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2","volume":"275","author":"Battistutta","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2019.105780_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmb.2008.01.008","article-title":"The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin","volume":"377","author":"Raaf","year":"2008","journal-title":"J. Mol. Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919312743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919312743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:45:45Z","timestamp":1762551945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919312743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":62,"alternative-id":["S1567576919312743"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105780","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rhein inhibits ATP-triggered inflammatory responses in rheumatoid rat fibroblast-like synoviocytes","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105780"}}